Gene · 4486
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance. | Nat Commun | 2022 | 36138008 | PubTator, text mining | PubMed |
| Nasopharyngeal Carcinoma Progression: Accumulating Genomic Instability and Persistent Epstein-Barr Virus Infection. | Curr Oncol | 2022 | 36135044 | PubTator, text mining | PubMed |
| Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma. | Cell Rep Med | 2022 | 36130479 | PubTator, text mining | PubMed |
| An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment. | Cancer Commun (Lond) | 2022 | 36129048 | PubTator, text mining | PubMed |
| Landscapes of synchronous multiple primary cancers detected by next-generation sequencing. | FEBS Open Bio | 2022 | 36128740 | PubTator, text mining | PubMed |
The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors. | J Exp Clin Cancer Res | 2022 | 36123711 | PubTator, text mining | PubMed |
| The Roles of Tumor-Associated Macrophages in Prostate Cancer. | J Oncol | 2022 | 36117852 | PubTator, text mining | PubMed |
| Rare POLN mutations confer risk for familial nasopharyngeal carcinoma through weakened Epstein-Barr virus lytic replication. | EBioMedicine | 2022 | 36116213 | PubTator, text mining | PubMed |
| Tyrosine kinase receptor RON activates MAPK/RSK/CREB signal pathway to enhance CXCR4 expression and promote cell migration and invasion in bladder cancer. | Aging (Albany NY) | 2022 | 36103228 | PubTator, text mining | PubMed |
| Epithelial-Mesenchymal Transition Gene Signature Is Associated with Neoadjuvant Chemoradiotherapy Resistance and Prognosis of Esophageal Squamous Cell Carcinoma. | Dis Markers | 2022 | 36072903 | PubTator, text mining | PubMed |
| Wound repair in sea urchin larvae involves pigment cells and blastocoelar cells. | Dev Biol | 2022 | 36067837 | PubTator, text mining | PubMed |
| NMR-based metabolomic analysis identifies RON-DEK-β-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival. | PLoS One | 2022 | 36067206 | PubTator, text mining | PubMed |
| Sex differences in saliva-based DNA methylation changes and environmental stressor in young African American adults. | PLoS One | 2022 | 36067197 | PubTator, text mining | PubMed |
| BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity. | Exp Mol Med | 2022 | 36056187 | PubTator, text mining | PubMed |
| The function and regulatory mechanism of RNA-binding proteins in breast cancer and their future clinical treatment prospects. | Front Oncol | 2022 | 36052258 | PubTator, text mining | PubMed |
| Discovery of novel conjugates of quinoline and thiazolidinone urea as potential anti-colorectal cancer agent. | J Enzyme Inhib Med Chem | 2022 | 36043496 | PubTator, text mining | PubMed |
| HIV-1 induction of tolerogenic dendritic cells is mediated by cellular interaction with suppressive T cells. | Front Immunol | 2022 | 36032117 | PubTator, text mining | PubMed |
| A Novel Splice Variant of BCAS1 Inhibits β-Arrestin 2 to Promote the Proliferation and Migration of Glioblastoma Cells, and This Effect Was Blocked by Maackiain. | Cancers (Basel) | 2022 | 36010884 | PubTator, text mining | PubMed |
| Identification and Characterization of Copy Number Variations Regions in West African Taurine Cattle. | Animals (Basel) | 2022 | 36009719 | PubTator, text mining | PubMed |
| Gene Ontology Analysis Highlights Biological Processes Influencing Non-Response to Anti-TNF Therapy in Rheumatoid Arthritis. | Biomedicines | 2022 | 36009355 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4486/papers?page=14